Effect of Intracoronary Streptokinase Administered Immediately After Primary Percutaneous Coronary Intervention on Long-Term Left Ventricular Infarct Size, Volumes, and Function
Murat Sezer, MD*,*,
Arif Çimen, MD*,
Emre Aslanger, MD*,
Ali Elitok, MD*,
Berrin Umman, MD*,
Zehra Bu ra, MD*,
Ebru Yormaz, MD ,
Cüneyt Türkmen, MD ,
I. k Adalet, MD ,
Yilmaz Ni anci, MD* and
Sabahattin Umman, MD*,
* Department of Cardiology, Istanbul University, Istanbul Faculty of Medicine, Capa-Istanbul, Turkey
Department of Nuclear Medicine, Istanbul University, Istanbul Faculty of Medicine, Capa-Istanbul, Turkey

View larger version (24K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 2 Comparison of Infarct Size, LV End-Diastolic and -Systolic Volumes, and Infarct Size Between the Groups
Differences between the intracoronary streptokinase (ICSK) and control groups with respect to scintigraphic and echocardiographic findings at long-term follow-up. LV = left ventricular.
|
|
|